Cologne And Covid: Can The Virus Affect Your Sense Of Smell?

can

The COVID-19 pandemic has brought the issue of anosmia, or loss of smell, into the spotlight. While it's not uncommon to experience changes in your sense of smell as you get older, losing your sense of smell can be a scary and isolating experience. Anosmia has been linked to emotional distress and even depression. It can also be dangerous, as our sense of smell often alerts us to potential harm, like the smell of smoke or a gas leak. For many, anosmia was the first sign that they had contracted COVID-19, and some have experienced long-term loss of smell even after recovering from the virus.

Characteristics Values
Percentage of people affected by smell dysfunction 50%–75%
Likely cause of smell dysfunction Damage to the cells that support and assist the olfactory neurons
Percentage of people who experience improvement within four weeks 90%
Phantom smell experienced by patients Smoke, rotten meat, etc.
Percentage of people who experience full recovery 78%
Time taken for people to experience a change to their sense of smell after infection 3 to 4 months
Percentage of people who regain their taste and smell 18 months after infection 65%
Percentage of people who get their senses back within two years 80% to 90%

shunscent

Anosmia is the medical term for loss of smell

Anosmia is the medical term for the loss of smell. It is usually a temporary side effect of a cold, sinus infection, or other respiratory issues, but it can also be a symptom of more serious medical issues like diabetes or traumatic brain injury. Anosmia can be partial or total, and specific to certain smells. Anosmia can also be congenital, meaning some people are born without the ability to smell.

Anosmia occurs when there is a problem or blockage in the process of smelling. This process involves the nose and the brain. The inside of the nose contains olfactory neurons, or odor receptors, that send messages to the brain about the scents they detect. When the brain receives these messages, it recognizes and identifies the smell.

Anosmia can be caused by a blocked nose, inflammation of the nasal mucosa, or infection. It can also be caused by more serious issues such as brain injuries, neurodegenerative diseases, or certain medications. Anosmia is a common symptom of COVID-19 and can persist as long COVID. In fact, loss of smell has been found to be more predictive of COVID-19 than other symptoms like fever, cough, or fatigue.

The loss of smell can have harmful effects on individuals. It can cause a loss of libido and increase the risk of food poisoning, smoke inhalation, and exposure to harmful chemicals and gas leaks. Anosmia can also be emotionally distressing and has been associated with depression.

Treatment options for anosmia include smell retraining therapy, medication, and surgery to remove blockages.

shunscent

Anosmia can cause depression

Anosmia, or the loss of smell, can be caused by a variety of factors, including head injuries, nasal congestion, and viral infections such as COVID-19. While it may not seem like a significant issue, the inability to smell can have a profound impact on a person's emotional well-being and mental health.

The sense of smell is closely linked to emotion and memory. The loss of smell can hinder our ability to detect dangerous situations, such as gas leaks or fires, and it can also affect our sense of taste, diminishing the pleasure we derive from eating. This can lead to a reduction in appetite and even weight loss.

Additionally, losing the ability to smell can be socially isolating. It can be challenging to describe the nature of this loss to others, and it may be difficult for those who have not experienced it to understand the impact it can have. This sense of isolation can contribute to feelings of depression and anxiety.

The impact of anosmia on mental health is not limited to those who have lost their sense of smell entirely. Even a diminished sense of smell can have negative consequences. A study found that around 60% of patients infected with SARS-CoV-2 in 2021 experienced some loss of taste or smell, and a quarter of those patients did not experience a full recovery, being left with a reduced sense of smell.

For individuals living with anosmia, the condition can cause significant emotional distress and depression. Treatment options are currently limited, but smell retraining and olfactory training can be helpful. Additionally, patient advocacy groups provide crucial support and resources to help individuals cope with the condition and adapt to the lifestyle changes it entails.

Colognes and Freezing: What's the Deal?

You may want to see also

shunscent

Anosmia can be caused by damage to the olfactory neurons

Anosmia, the loss or impairment of the sense of smell, can be caused by damage to the olfactory neurons. This can occur as a result of head trauma, brain trauma, traumatic brain damage, or a traumatic brain injury (TBI). The term "post-traumatic anosmia" is often used to describe the loss or impairment of olfactory functions due to head or brain injuries.

Olfactory neurons are responsible for transmitting information about odours to the brain, allowing us to perceive and identify different smells. When these neurons are damaged, the transmission of smell information to the brain is disrupted, leading to a loss of the sense of smell.

Mild, moderate, or severe brain injuries can all result in anosmia. It is important to note that the loss of smell can be overlooked by doctors if they do not specifically test for this condition or inquire about changes in a patient's sense of smell. Standard examinations of the nose and nasal cavity, as well as MRI tests, can be conducted to determine anosmia symptoms.

The COVID-19 pandemic has brought anosmia into the spotlight, as a loss of smell is a common symptom of the infection. However, it is important to note that many other viruses, such as the common cold, can also cause smell dysfunction.

The impact of anosmia can be significant, affecting not only one's enjoyment of everyday life but also their personal safety. It can lead to an increased risk of consuming spoiled food, difficulty detecting gas leaks or toxic fumes, and changes in eating habits, resulting in weight loss or gain. Additionally, losing the ability to smell can be emotionally distressing and has been associated with depression.

shunscent

Anosmia can be caused by damage to the sustentacular cells

The loss of smell, or anosmia, can be caused by damage to the sustentacular cells in the olfactory epithelium. These cells support and assist olfactory neurons, and their damage can lead to a reduced sense of smell.

The olfactory epithelium is a specialised tissue in the roof of the nasal cavity that houses olfactory sensory neurons and a variety of supporting cells. Sustentacular cells are one type of supporting cell, and they play a crucial role in olfaction. They express the ACE2 receptor, which is a functional SARS-CoV-2 receptor, making them vulnerable to infection by the virus.

When sustentacular cells are infected, it can lead to inflammation and the infiltration of myeloid cells into the olfactory epithelium. This can cause widespread damage to olfactory sensory neurons and their cilia, which are essential for odour detection. The damage to the cilia can disrupt the normal functioning of olfactory sensory neurons, leading to a loss of smell.

In addition, sustentacular cells regulate the extracellular ionic environment required for the normal functioning of olfactory sensory neurons. They also produce neurotrophic and neuromodulatory molecules, phagocytose dead and dying cells, and eliminate noxious substances. Damage to sustentacular cells can, therefore, have a significant impact on the function of olfactory sensory neurons and contribute to anosmia.

Studies have shown that SARS-CoV-2 infection of sustentacular cells can lead to a reduction in the expression of genes involved in olfactory signal transduction, such as Golf, CNGA2, and ACIII. This downregulation of key molecules in the olfactory signalling pathway can further contribute to the loss of smell observed in COVID-19 patients.

Furthermore, infection of sustentacular cells can lead to altered expression of olfactory receptors, which are essential for odour recognition. The altered profile of olfactory receptor expression during the recovery phase from infection raises the possibility of distorted or hallucinated senses of smell in COVID-19 survivors.

While most COVID-19 patients with anosmia recover their sense of smell within a few weeks, there is a subset of individuals who experience prolonged or even permanent olfactory dysfunction. The underlying mechanisms of this persistent anosmia are not yet fully understood and require further investigation.

shunscent

Smell retraining can help treat anosmia

Anosmia, or the loss of smell, can be a devastating condition that has been linked to depression and emotional distress. It is a common symptom of COVID-19, with an estimated 60% of patients infected in 2021 experiencing some loss of smell or taste. While most people recover their sense of smell within a few weeks, some may experience a permanent loss or long-term impairment.

One therapeutic option for treating anosmia is smell retraining, also known as olfactory training. This involves stimulating and retraining the olfactory system through regular, intermittent exposure to odors. Patients are given a set of four to five non-irritating odors, such as perfumes, coffee grounds, or flavor extracts, and are asked to smell, discriminate, and identify them a couple of times each day. This process can help to improve olfaction, especially if started within 12 months of the onset of the disorder.

The University of Pennsylvania Smell Identification Test (UPSIT) is a commonly used assessment tool to gauge the severity of anosmia. It involves a scratch-and-sniff test, where patients are asked to identify different scents. Based on the number of correct answers, clinicians can determine the extent of the patient's loss of smell.

During smell retraining, patients are initially provided with four scents: lemon, rose, eucalyptus, and cloves. Twice a day, they smell these scents for about 15 seconds each, trying to recall how they remember these scents. After three months, the clinician reevaluates the patient's anosmia and introduces four new scents. This process is repeated at the six-month mark, so that by the end of the program, patients have been exposed to 12 different scents. Other common scents used in testing include orange, banana, apple, coffee, cinnamon, garlic, leather, and peppermint.

While there is no guaranteed cure for anosmia, smell retraining has shown promising results in helping individuals regain their sense of smell. It is important to seek evaluation from a board-certified otolaryngologist (ear, nose, and throat specialist) to determine the underlying cause of anosmia and discuss possible treatment options.

Frequently asked questions

Loss of smell, or anosmia, is a common symptom of COVID-19. It is also often one of the first signs of infection.

With most viral infections, loss of smell occurs after other symptoms such as congestion and a runny nose. With COVID-19, loss of smell tends to happen at the beginning of the infection.

If you experience loss of smell, you should self-isolate and get tested for COVID-19.

Approximately 90% of those affected can expect an improvement within four weeks. However, it can take months or even years to recover your sense of smell, and some will experience a permanent loss.

While there is no proven treatment for loss of smell, olfactory training is recommended. Topical corticosteroid sprays are also often used in short-term treatment.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment